The U.S. allergy and autoimmune disease diagnostics market, valued at USD 4.24 billion in 2024, is anticipated to expand at a CAGR of 8.5% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, end-user applications, and technological platforms. The market can be segmented by product type into immunoassay analyzers, reagent kits, rapid tests, and...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek